(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202203 | 202103 | % Var | 202203 | 202103 | % Var | 202203 | 202103 | % Var | |
| Sales | 28871.70 | 41140.30 | -29.82 | 112871.40 | 158236.80 | -28.67 | 112871.40 | 158236.80 | -28.67 |
| Other Income | 4133.70 | 2674.20 | 54.58 | 6709.90 | 5898.60 | 13.75 | 6709.90 | 5898.60 | 13.75 |
| PBIDT | 9203.40 | 12434.50 | -25.98 | 21443.90 | 47096.90 | -54.47 | 21443.90 | 47096.90 | -54.47 |
| Interest | 49.10 | 59.30 | -17.20 | 169.40 | 286.80 | -40.93 | 169.40 | 286.80 | -40.93 |
| PBDT | 8407.20 | 12375.20 | -32.06 | 20527.40 | 46810.10 | -56.15 | 20527.40 | 46810.10 | -56.15 |
| Depreciation | 1012.20 | 1240.70 | -18.42 | 4152.60 | 4880.00 | -14.91 | 4152.60 | 4880.00 | -14.91 |
| PBT | 7395.00 | 11134.50 | -33.58 | 16374.80 | 41930.10 | -60.95 | 16374.80 | 41930.10 | -60.95 |
| TAX | -626.60 | 2408.70 | -126.01 | 1827.70 | 10801.00 | -83.08 | 1827.70 | 10801.00 | -83.08 |
| Deferred Tax | -880.70 | 318.90 | -376.17 | -1969.30 | 367.60 | -635.72 | -1969.30 | 367.60 | -635.72 |
| PAT | 8021.60 | 8725.80 | -8.07 | 14547.10 | 31129.10 | -53.27 | 14547.10 | 31129.10 | -53.27 |
| Equity | 585.90 | 585.90 | 0.00 | 585.90 | 585.90 | 0.00 | 585.90 | 585.90 | 0.00 |
| PBIDTM(%) | 31.88 | 30.22 | 5.47 | 19.00 | 29.76 | -36.17 | 19.00 | 29.76 | -36.17 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1679.85 |
| Dr. Reddys Lab | 1333.05 |
| Cipla | 1305.85 |
| Zydus Lifesciences | 947.10 |
| Lupin | 2340.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: